Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 05
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
DexCom Inc
DXCM
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$85.82
0.46
0.54%
Ult. Agg.: Oct 5, 9:27 AM
$85.82
0.46
0.54%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
DexCom Analyst Price Targets - Benzinga
DexCom Analyst Price Targets
Wall Street analyst price targets and consensus rating for DexCom (DXCM).
Analyst Ratings News
PRO
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105
RBC Capital analyst Kendall Au maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $105.
Benzinga Newsdesk
PRO
Truist Securities Maintains Buy on DexCom, Raises Price Target to $102
Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $93 to $102.
Benzinga Newsdesk
PRO
TD Cowen Reiterates Buy on DexCom, Maintains $95 Price Target
TD Cowen analyst Joshua Jennings reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $95 price target.
Benzinga Newsdesk
PRO
Argus Research Maintains Buy on DexCom, Raises Price Target to $96
Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.
Benzinga Newsdesk
PRO
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $90
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $82 to $90.
Benzinga Newsdesk
PRO
Citigroup Maintains Buy on DexCom, Raises Price Target to $88
Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $84 to $88.
Benzinga Newsdesk
Crea una watchlist
GRATIS: Segui le azioni e criptovalute con le migliori notifiche di internet
Clicca per iniziare
People Also Watch
Abbott Laboratories
NYSE:ABT
$98.1
-1.98%
Intuitive Surgical Inc
NASDAQ:ISRG
$389.33
-4.38%
Medtronic PLC
NYSE:MDT
$86.33
-1.89%
Stryker Corp
NYSE:SYK
$275.5
-3.54%
Boston Scientific Corp
NYSE:BSX
$42.47
-0.13%
Becton Dickinson & Co
NYSE:BDX
$176.8
-2.05%
Edwards Lifesciences Corp
NYSE:EW
$85
-2.62%
IDEXX Laboratories Inc
NASDAQ:IDXX
$516.36
-2.08%
ResMed Inc
NYSE:RMD
$218.84
-1.91%
GE HealthCare Technologies Inc
NASDAQ:GEHC
$63.47
-3.32%
Mostra tutte le 10 aziende correlate
